Form 4: National Healthcare Corp Director Exercises Stock Options
SEC Form 4
James Paul Abernathy, a director at National Healthcare Corp, exercised stock options on February 20, 2025, acquiring 1,745 shares of common stock.
Summary
- On February 20, 2025, James Paul Abernathy, a director of National Healthcare Corp (NHC), exercised stock options to purchase 1,745 shares of common stock at a price of $71.64 per share.
- This transaction increased Abernathy's direct holdings to 35,023 shares of common stock.
- The exercised options were granted on May 6, 2021, under the company's 2020 Omnibus Equity Incentive Plan.
- Abernathy also holds options to purchase additional shares of common stock at various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing related to stock option exercises. It doesn't contain overtly positive or negative information, but the director's exercise of options could be interpreted as a mildly positive signal.
Positives
- The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Stock option exercises are a common part of executive compensation in the healthcare industry. They are designed to align the interests of management with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in the healthcare industry to incentivize performance and align management interests with shareholder value.
- Companies like Brookdale Senior Living and Life Care Centers of America also utilize stock options as part of their executive compensation plans.
- The specific terms of these option grants, such as exercise price and vesting schedules, are typically benchmarked against industry peers to ensure competitiveness.
Stakeholder Impact
- The exercise of stock options has a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/06/2021 | Date of grant for the exercised stock options under the 2020 Omnibus Equity Incentive Plan. |
| 05/06/2021 | Grant date of options to purchase 5,755 shares at $71.64. |
| 05/05/2023 | Grant date of options to purchase 7,500 shares at $69.19. |
| 05/04/2024 | Grant date of options to purchase 7,500 shares at $55.75. |
| 05/09/2025 | Grant date of options to purchase 7,500 shares at $96.03. |
| 02/20/2025 | Date of the stock option exercise. |
| 05/05/2026 | Expiration date of options to purchase 5,755 shares at $71.64. |
| 05/04/2027 | Expiration date of options to purchase 7,500 shares at $69.19. |
| 05/03/2028 | Expiration date of options to purchase 7,500 shares at $55.75. |
| 05/08/2029 | Expiration date of options to purchase 7,500 shares at $96.03. |
Keywords
stock options, Form 4, director, NHC, National Healthcare Corp, Abernathy, equity incentive plan, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.